Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


APhA on natural products

This article was originally published in The Tan Sheet

Executive Summary

Natural Products: A Case-Based Approach for Health Care Professionals has been published by the American Pharmacists Association in order to "help health care practitioners evaluate natural products used in treating 14 common conditions," the association announces April 19. The book is authored by APhA member Karen Shapiro, Department of Medicine, Rancho Los Amigos National Rehabilitation Center, Los Angeles. The publication devotes one chapter to each of the 14 common conditions, which include migraine, osteoarthritis, erectile dysfunction, cholesterol reduction, cardiovascular disease, flu, weight loss and performance enhancement. It discusses commonly used natural products as well as their dosages and effects, and provides "extensive references demonstrating the scientific evidence for use or avoidance of each product," APhA states. Dialogue suggestions about safety considerations and drug interactions also are included. The book can be purchased through APhA by phone or through the group's website...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts